Kanavos

Kanavos is developing a Semantic AI Knowledge Graph to provide cannabis patients a unified source of truth to discover scientific evidence-based therapeutic treatments with provenance empowering personalized actionable decisions. Kanavos is a leader in the rapidly evolving Novel Cannabinoid Therapeutic Industry focusing on developing new cannabinoid-based medications and treatments, exploring the potential of the endocannabinoid system for various health conditions Kanavos is developing a comprehensive Cannabis Knowledge Graph that empowers patients with personalized, actionable insights derived from scientific evidence-based research. This innovative solution will leverage the value of domain-specific cannabinoid knowledge, integrating data from clinical trials, preclinical research, and real-world evidence to provide patients with the most up-to-date and relevant information. Kanavos has announced a strategic partnership with Graphwise, a global leader in advanced knowledge graph and semantic AI technologies. By leveraging Graphwise's Semantic AI technology, Kanavos is developing a comprehensive Knowledge Graph to provide patients interested in using cannabis with a unified source of truth to discover scientific evidence-based, therapeutic treatments empowering personalized actionable decisions. It combines the power of AI, domain knowledge and data to deliver actionable insights with meaning and context, by analyzing relationships between words. whereas "generative AI" is primarily concerned with creating new content like text, images, or code based on learned patterns, essentially generating original outputs rather than understanding the meaning of the data. Companies in The Novel Cannabinoid Therapeutic Industry are working to understand how novel cannabinoids interact with the endocannabinoid system & other biological pathways to exert their therapeutic effects & their unique therapeutic properties targeting specific targets.